RetnaGene is designed to evaluate the risk of patients with AMD progressing to advanced chorodial neovascular disease.
More Articles on Ophthalmology:
Dr. David Risner Joins Heaton Eye Associates in Texas
Geneva Eye Clinic Partners With Foundation Fighting Blindness
US Commerce Association Recognizes Dr. Jonathan Frantz, Frantz EyeCare
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
